JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 33 No. 5 716-723
© 1992 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glowniak, J. V.
Right arrow Articles by Turner, F. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glowniak, J. V.
Right arrow Articles by Turner, F. E.

Evaluation of Metaiodobenzylguanidine Heart and Lung Extraction Fraction by First-Pass Analysis in Pigs

Jerry V. Glowniak, Richard A. Wilson, Mary E. Joyce and Frederick E. Turner

Departments of Nuclear Medicine and Internal Medicine, Division of Cardiology, Veteran's Affairs Medical Center
Oregon Health Sciences University, Portland, Oregon

Correspondence: For reprints contact: Jerry V. Glowniak, MD, Nuclear Medicine Service, VA Medical Center, PO Box 1034, Portland, OR 97207.

ABSTRACT

Metaiodobenzylguanidine (MIBG) is a norepinephrine analog that can be used to study cardiac sympathetic innervation. Most of the kinetic data on MIBG, however, have been obtained in vitro from adrenal chromaffin cells. To elucidate MIBG cardiac kinetics in vivo, we measured the first-pass extraction fraction (EF) of MIBG in pig heart and lungs and determined the relationship between the cardiac EF and myocardial blood flow (MBF) before and after dipyridamole, cocaine and imipramine. The first-pass lung EF was 24% ± 0.80% (mean ± s.e.). The baseline cardiac EF of MIBG was 79% ± 1.6%. With dipyridamole, MBF increased significantly and the EF fell (82% ± 2.5% to 71% ± 3.5% baseline compared to 0.03 mg/kg/min dipyridamole, p < 0.001), indicating that the cardiac EF of MIBG is dependent on MBF. Cocaine infusion had no effect on MBF or EF. Imipramine caused a significant increase in the EF (72% ± 3.5% versus 77% ± 2.5%, baseline versus imipramine p = 0.032) without a change in MBF. In adrenal chromaffin cells, cocaine and imipramine decrease MIBG uptake, suggesting that adrenal chromaffin cells may be an inappropriate model for studying MIBG kinetics in cardiac sympathetic neurons.




This article has been cited by other articles:


Home page
JNMHome page
K. Mardon, O. Montagne, N. Elbaz, Z. Malek, A. Syrota, J.-L. Dubois-Rande, M. Meignan, and P. Merlet
Uptake-1 Carrier Downregulates in Parallel with the {beta}-Adrenergic Receptor Desensitization in Rat Hearts Chronically Exposed to High Levels of Circulating Norepinephrine: Implications for Cardiac Neuroimaging in Human Cardiomyopathies
J. Nucl. Med., September 1, 2003; 44(9): 1459 - 1466.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1992 by the Society of Nuclear Medicine.